IBDEI0I5 ; ; 09-AUG-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,22994,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22994,1,3,0)
 ;;=3^Huntington's Disease w/ Dementia w/ Behavioral Disturbance
 ;;^UTILITY(U,$J,358.3,22994,1,4,0)
 ;;=4^G10.
 ;;^UTILITY(U,$J,358.3,22994,2)
 ;;=^5003751^F02.81
 ;;^UTILITY(U,$J,358.3,22995,0)
 ;;=G10.^^58^860^20
 ;;^UTILITY(U,$J,358.3,22995,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22995,1,3,0)
 ;;=3^Huntington's Disease w/ Dementia w/o Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,22995,1,4,0)
 ;;=4^G10.
 ;;^UTILITY(U,$J,358.3,22995,2)
 ;;=^5003751^F02.80
 ;;^UTILITY(U,$J,358.3,22996,0)
 ;;=G90.3^^58^860^21
 ;;^UTILITY(U,$J,358.3,22996,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22996,1,3,0)
 ;;=3^Multi-System Degeneration of the Autonomic Nervous System
 ;;^UTILITY(U,$J,358.3,22996,1,4,0)
 ;;=4^G90.3
 ;;^UTILITY(U,$J,358.3,22996,2)
 ;;=^5004162
 ;;^UTILITY(U,$J,358.3,22997,0)
 ;;=G91.2^^58^860^22
 ;;^UTILITY(U,$J,358.3,22997,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22997,1,3,0)
 ;;=3^NPH w/ Dementia w/ Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,22997,1,4,0)
 ;;=4^G91.2
 ;;^UTILITY(U,$J,358.3,22997,2)
 ;;=^5004174^F02.81
 ;;^UTILITY(U,$J,358.3,22998,0)
 ;;=G91.2^^58^860^23
 ;;^UTILITY(U,$J,358.3,22998,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22998,1,3,0)
 ;;=3^NPH w/ Dementia w/o Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,22998,1,4,0)
 ;;=4^G91.2
 ;;^UTILITY(U,$J,358.3,22998,2)
 ;;=^5004174^F02.80
 ;;^UTILITY(U,$J,358.3,22999,0)
 ;;=G30.8^^58^860^5
 ;;^UTILITY(U,$J,358.3,22999,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22999,1,3,0)
 ;;=3^Alzheimer's Diseases NEC
 ;;^UTILITY(U,$J,358.3,22999,1,4,0)
 ;;=4^G30.8
 ;;^UTILITY(U,$J,358.3,22999,2)
 ;;=^5003807
 ;;^UTILITY(U,$J,358.3,23000,0)
 ;;=G31.09^^58^860^16
 ;;^UTILITY(U,$J,358.3,23000,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23000,1,3,0)
 ;;=3^Frontotemporal Dementia NEC
 ;;^UTILITY(U,$J,358.3,23000,1,4,0)
 ;;=4^G31.09
 ;;^UTILITY(U,$J,358.3,23000,2)
 ;;=^329916
 ;;^UTILITY(U,$J,358.3,23001,0)
 ;;=G20.^^58^860^24
 ;;^UTILITY(U,$J,358.3,23001,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23001,1,3,0)
 ;;=3^Parkinson's Disease w/ Dementia w/ Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,23001,1,4,0)
 ;;=4^G20.
 ;;^UTILITY(U,$J,358.3,23001,2)
 ;;=^5003770^F02.81
 ;;^UTILITY(U,$J,358.3,23002,0)
 ;;=G20.^^58^860^25
 ;;^UTILITY(U,$J,358.3,23002,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23002,1,3,0)
 ;;=3^Parkinson's Disease w/ Dementia w/o Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,23002,1,4,0)
 ;;=4^G20.
 ;;^UTILITY(U,$J,358.3,23002,2)
 ;;=^5003770^F02.80
 ;;^UTILITY(U,$J,358.3,23003,0)
 ;;=G31.01^^58^860^26
 ;;^UTILITY(U,$J,358.3,23003,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23003,1,3,0)
 ;;=3^Pick's Disease
 ;;^UTILITY(U,$J,358.3,23003,1,4,0)
 ;;=4^G31.01
 ;;^UTILITY(U,$J,358.3,23003,2)
 ;;=^329915
 ;;^UTILITY(U,$J,358.3,23004,0)
 ;;=G23.1^^58^860^28
 ;;^UTILITY(U,$J,358.3,23004,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23004,1,3,0)
 ;;=3^Progressive Supranuclear Ophthalmoplegia
 ;;^UTILITY(U,$J,358.3,23004,1,4,0)
 ;;=4^G23.1
 ;;^UTILITY(U,$J,358.3,23004,2)
 ;;=^5003780
 ;;^UTILITY(U,$J,358.3,23005,0)
 ;;=Z79.2^^58^861^1
 ;;^UTILITY(U,$J,358.3,23005,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23005,1,3,0)
 ;;=3^Antibiotics
 ;;^UTILITY(U,$J,358.3,23005,1,4,0)
 ;;=4^Z79.2
 ;;^UTILITY(U,$J,358.3,23005,2)
 ;;=^321546
 ;;^UTILITY(U,$J,358.3,23006,0)
 ;;=Z79.01^^58^861^2
 ;;^UTILITY(U,$J,358.3,23006,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23006,1,3,0)
 ;;=3^Anticoagulants
 ;;^UTILITY(U,$J,358.3,23006,1,4,0)
 ;;=4^Z79.01
 ;;^UTILITY(U,$J,358.3,23006,2)
 ;;=^5063330
 ;;^UTILITY(U,$J,358.3,23007,0)
 ;;=Z79.02^^58^861^3
 ;;^UTILITY(U,$J,358.3,23007,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23007,1,3,0)
 ;;=3^Antiplatelets/Antithrombotics
 ;;^UTILITY(U,$J,358.3,23007,1,4,0)
 ;;=4^Z79.02
 ;;^UTILITY(U,$J,358.3,23007,2)
 ;;=^5063331
 ;;^UTILITY(U,$J,358.3,23008,0)
 ;;=Z79.82^^58^861^4
 ;;^UTILITY(U,$J,358.3,23008,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23008,1,3,0)
 ;;=3^Aspirin
 ;;^UTILITY(U,$J,358.3,23008,1,4,0)
 ;;=4^Z79.82
 ;;^UTILITY(U,$J,358.3,23008,2)
 ;;=^5063340
 ;;^UTILITY(U,$J,358.3,23009,0)
 ;;=Z79.4^^58^861^5
 ;;^UTILITY(U,$J,358.3,23009,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23009,1,3,0)
 ;;=3^Insulin
 ;;^UTILITY(U,$J,358.3,23009,1,4,0)
 ;;=4^Z79.4
 ;;^UTILITY(U,$J,358.3,23009,2)
 ;;=^5063334
 ;;^UTILITY(U,$J,358.3,23010,0)
 ;;=Z79.1^^58^861^7
 ;;^UTILITY(U,$J,358.3,23010,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23010,1,3,0)
 ;;=3^NSAID
 ;;^UTILITY(U,$J,358.3,23010,1,4,0)
 ;;=4^Z79.1
 ;;^UTILITY(U,$J,358.3,23010,2)
 ;;=^5063332
 ;;^UTILITY(U,$J,358.3,23011,0)
 ;;=Z79.891^^58^861^8
 ;;^UTILITY(U,$J,358.3,23011,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23011,1,3,0)
 ;;=3^Opiate Analgesic
 ;;^UTILITY(U,$J,358.3,23011,1,4,0)
 ;;=4^Z79.891
 ;;^UTILITY(U,$J,358.3,23011,2)
 ;;=^5063342
 ;;^UTILITY(U,$J,358.3,23012,0)
 ;;=Z79.51^^58^861^9
 ;;^UTILITY(U,$J,358.3,23012,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23012,1,3,0)
 ;;=3^Steroids-Inhaled
 ;;^UTILITY(U,$J,358.3,23012,1,4,0)
 ;;=4^Z79.51
 ;;^UTILITY(U,$J,358.3,23012,2)
 ;;=^5063335
 ;;^UTILITY(U,$J,358.3,23013,0)
 ;;=Z79.52^^58^861^10
 ;;^UTILITY(U,$J,358.3,23013,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23013,1,3,0)
 ;;=3^Steroids-Systemic
 ;;^UTILITY(U,$J,358.3,23013,1,4,0)
 ;;=4^Z79.52
 ;;^UTILITY(U,$J,358.3,23013,2)
 ;;=^5063336
 ;;^UTILITY(U,$J,358.3,23014,0)
 ;;=Z79.899^^58^861^6
 ;;^UTILITY(U,$J,358.3,23014,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23014,1,3,0)
 ;;=3^Long Term Current Drug Therapy NEC
 ;;^UTILITY(U,$J,358.3,23014,1,4,0)
 ;;=4^Z79.899
 ;;^UTILITY(U,$J,358.3,23014,2)
 ;;=^5063343
 ;;^UTILITY(U,$J,358.3,23015,0)
 ;;=96101^^59^862^43^^^^1
 ;;^UTILITY(U,$J,358.3,23015,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23015,1,2,0)
 ;;=2^96101
 ;;^UTILITY(U,$J,358.3,23015,1,3,0)
 ;;=3^PSYCH TST,PSYCH/PHYS,PER HR W/ INTERP & RPT
 ;;^UTILITY(U,$J,358.3,23016,0)
 ;;=96102^^59^862^42^^^^1
 ;;^UTILITY(U,$J,358.3,23016,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23016,1,2,0)
 ;;=2^96102
 ;;^UTILITY(U,$J,358.3,23016,1,3,0)
 ;;=3^PSYCH TST,ADMIN BY TECH,PER HR W/ INTERP & RPT
 ;;^UTILITY(U,$J,358.3,23017,0)
 ;;=96118^^59^862^36^^^^1
 ;;^UTILITY(U,$J,358.3,23017,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23017,1,2,0)
 ;;=2^96118
 ;;^UTILITY(U,$J,358.3,23017,1,3,0)
 ;;=3^NEUROPSYCH TST,PSYCH/PHYS,PER HR W/ INTERP & RPT
 ;;^UTILITY(U,$J,358.3,23018,0)
 ;;=96119^^59^862^35^^^^1
 ;;^UTILITY(U,$J,358.3,23018,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23018,1,2,0)
 ;;=2^96119
 ;;^UTILITY(U,$J,358.3,23018,1,3,0)
 ;;=3^NEUROPSYCH TST,ADMIN BY TECH,PER HR W/ INTERP & RPT
 ;;^UTILITY(U,$J,358.3,23019,0)
 ;;=96120^^59^862^34^^^^1
 ;;^UTILITY(U,$J,358.3,23019,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23019,1,2,0)
 ;;=2^96120
 ;;^UTILITY(U,$J,358.3,23019,1,3,0)
 ;;=3^NEUROPSYCH TST,ADMIN BY COMPUTER W/ INTERP & RPT
 ;;^UTILITY(U,$J,358.3,23020,0)
 ;;=96125^^59^862^55^^^^1
 ;;^UTILITY(U,$J,358.3,23020,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23020,1,2,0)
 ;;=2^96125
 ;;^UTILITY(U,$J,358.3,23020,1,3,0)
 ;;=3^STANDARDIZED COGNITIVE PERFORM TST,PER HR W/ INTERP & RPT
 ;;^UTILITY(U,$J,358.3,23021,0)
 ;;=90882^^59^862^18^^^^1
 ;;^UTILITY(U,$J,358.3,23021,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23021,1,2,0)
 ;;=2^90882
 ;;^UTILITY(U,$J,358.3,23021,1,3,0)
 ;;=3^ENVIRONM INTERV FOR MED MGMT W/ EMPLOYER/AGENCY/INSTITUTION
 ;;^UTILITY(U,$J,358.3,23022,0)
 ;;=90887^^59^862^13^^^^1
 ;;^UTILITY(U,$J,358.3,23022,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23022,1,2,0)
 ;;=2^90887
 ;;^UTILITY(U,$J,358.3,23022,1,3,0)
 ;;=3^CONSULTATION W/ FAMILY FOR INTERP/EXPLAN EXAM/TEST RESULTS
 ;;^UTILITY(U,$J,358.3,23023,0)
 ;;=96105^^59^862^7^^^^1
 ;;^UTILITY(U,$J,358.3,23023,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23023,1,2,0)
 ;;=2^96105
 ;;^UTILITY(U,$J,358.3,23023,1,3,0)
 ;;=3^ASSESSMENT OF APHASIA W/ INTERP & RPT,PER HR BY PHD/PHYS
 ;;^UTILITY(U,$J,358.3,23024,0)
 ;;=96103^^59^862^41^^^^1
 ;;^UTILITY(U,$J,358.3,23024,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23024,1,2,0)
 ;;=2^96103
 ;;^UTILITY(U,$J,358.3,23024,1,3,0)
 ;;=3^PSYCH TST ADMIN BY COMPUTER W/ INTER & RPT
 ;;^UTILITY(U,$J,358.3,23025,0)
 ;;=96110^^59^862^16^^^^1
 ;;^UTILITY(U,$J,358.3,23025,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23025,1,2,0)
 ;;=2^96110
 ;;^UTILITY(U,$J,358.3,23025,1,3,0)
 ;;=3^DEVELOPMENTAL SCREEN w/ SCORE & DOCUM,BY PHD/PHYS
 ;;^UTILITY(U,$J,358.3,23026,0)
 ;;=96111^^59^862^17^^^^1
 ;;^UTILITY(U,$J,358.3,23026,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23026,1,2,0)
 ;;=2^96111
 ;;^UTILITY(U,$J,358.3,23026,1,3,0)
 ;;=3^DEVELOPMENTAL TEST W/ INTERP & RPT
 ;;^UTILITY(U,$J,358.3,23027,0)
 ;;=96116^^59^862^33^^^^1
 ;;^UTILITY(U,$J,358.3,23027,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23027,1,2,0)
 ;;=2^96116
 ;;^UTILITY(U,$J,358.3,23027,1,3,0)
 ;;=3^NEUROBEHAV STATUS EXAM,PSYCH/PHYS PER HR
 ;;^UTILITY(U,$J,358.3,23028,0)
 ;;=97532^^59^862^10^^^^1
 ;;^UTILITY(U,$J,358.3,23028,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23028,1,2,0)
 ;;=2^97532
 ;;^UTILITY(U,$J,358.3,23028,1,3,0)
 ;;=3^COGNITIVE SKILLS DEVELOPMENT,EA 15 MIN
 ;;^UTILITY(U,$J,358.3,23029,0)
 ;;=97537^^59^862^12^^^^1
 ;;^UTILITY(U,$J,358.3,23029,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23029,1,2,0)
 ;;=2^97537
 ;;^UTILITY(U,$J,358.3,23029,1,3,0)
 ;;=3^COMMUNITY/WORK REINTEGRATION EA 15 MIN,BY PHD/PHYS
 ;;^UTILITY(U,$J,358.3,23030,0)
 ;;=97545^^59^862^62^^^^1
 ;;^UTILITY(U,$J,358.3,23030,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23030,1,2,0)
 ;;=2^97545
 ;;^UTILITY(U,$J,358.3,23030,1,3,0)
 ;;=3^WORK HARDENING CONDITIONING,2 HRS
 ;;^UTILITY(U,$J,358.3,23031,0)
 ;;=97546^^59^862^63^^^^1
 ;;^UTILITY(U,$J,358.3,23031,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23031,1,2,0)
 ;;=2^97546
